Skip directly to Accessibility Notice

PPH
VanEck Pharmaceutical ETF

Fund Description

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS®US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 09/17/21

  • 30-Day SEC Yield1

    1.61%
  • Total Net Assets

    $321.1M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.42%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Quarterly

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    4,388,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.07%
  • Gross Expense Ratio

    0.42%
  • Fee Waivers and
    Expense Reimbursement

    -0.07%
  • Net Expense Ratio/TER2

    0.35%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2022. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Investment Professionals

  • Portfolio Manager and Head of Equity ETFs
  • Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
  • Joined VanEck in 2005
  • CFA charterholder; member of the CFA Society New York
  • BA, Mathematics and Economics, New York University
  • Portfolio Manager and Analyst for Equity ETFs
  • Joined VanEck in 2007
  • Prior to his current role, held a portfolio administration position at VanEck
  • Previously, Portfolio Analyst at Evaluation Associates
  • BS, Business Administration (concentration in Financial Analysis), State University of New York at Buffalo
  • Analyst for Equity ETFs
  • Joined VanEck in 2018
  • Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
  • BS, Finance, Providence College
  • Analyst for Equity ETFs
  • Joined VanEck in 2019
  • Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
  • BS, Accounting, Hunter College

Prices as of 09/17/21

NAV/
Market Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
30-Day
Median
Bid Ask
Spread
NAV
Chart
PPH $73.17
$73.22
26,539
70,993
-$0.45 / -0.61%
$-0.49 / -0.66%
+11.57%
+11.51%
$0.05
0.06%
0.04%

Premium/Discount History as of 09/17/21

Calendar Year 2020 3Q 2020 4Q 2020 1Q 2021 2Q 2021 Premium/Discount Charts NAV & Prem/Discount History
Days closed at a premium 124 29 41 32 37
PPH Days closed at NAV 17 8 1 6 5
Days closed at a discount 112 27 22 23 21


Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.62 5.76 15.91 19.99 8.04 7.18 -- 10.26
PPH (Share Price) 1.58 5.80 15.90 19.86 8.05 7.19 -- 10.38
MVPPHTR (Index) 1.60 5.65 15.21 19.66 7.77 7.03 10.20 10.16
Performance Differential (NAV - Index) 0.02 0.11 0.70 0.33 0.27 0.15 -- 0.10
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.15 6.42 10.86 19.31 9.28 6.41 -- 9.94
PPH (Share Price) 1.26 6.40 10.92 19.38 9.34 6.45 -- 10.06
MVPPHTR (Index) 1.17 6.38 10.32 19.01 9.05 6.29 -- 9.85
Performance Differential (NAV - Index) -0.02 0.04 0.54 0.30 0.23 0.12 -- 0.09

Top 10 Holdings (%) as of 08/31/21 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
NOVO NORDISK A/S
NVO US
194,986
19,492,750 5.71
ASTRAZENECA PLC
AZN US
333,169
19,417,089 5.69
PFIZER INC
PFE US
408,929
18,839,359 5.52
ELI LILLY AND CO
LLY US
72,033
18,605,404 5.45
ABBVIE INC
ABBV US
142,802
17,247,626 5.06
JOHNSON & JOHNSON
JNJ US
98,312
17,020,757 4.99
ZOETIS INC
ZTS US
82,921
16,962,320 4.97
CATALENT INC
CTLT US
129,865
16,939,591 4.96
MERCK & CO INC
MRK US
219,872
16,774,035 4.92
BRISTOL-MYERS SQUIBB CO
BMY US
248,921
16,642,858 4.88
Top 10 Total (%) 52.15
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 08/31/21

  • Country

    % of Net Assets
  • United States

    66.52
  • United Kingdom

    10.11
  • Denmark

    5.71
  • Switzerland

    4.78
  • France

    4.68
  • Japan

    4.17
  • Israel

    3.22
  • Ireland

    0.71
  • Other/Cash

    0.09

Sector Weightings (%) as of 08/31/21

  • Sector

    % of Net Assets
  • Health Care

    97.4
  • n/a

    2.6
  • Other/Cash

    0.1